Anivamersen (sodium)
Product Specifications
UNSPSC Description
Anivamersen sodium is an RNA aptamer to reverse the anticoagulant effect of the parenteral factor IXa inhibitor pegnivacogin. REG1 is a novel anticoagulation system consisting of pegnivacogin, an RNA aptamer inhibitor of coagulation factor IXa, and anivamersen, a complementary sequence reversal oligonucleotide.
Target Antigen
Others
Type
Oligonucleotides
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/anivamersen-sodium.html
Solubility
10 mM in H2O
Smiles
[Anivamersen (sodium)]
Molecular Weight
5269.10
References & Citations
[1]Lincoff AM, Mehran R, Povsic TJ, et al. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial [published correction appears in Lancet. 2016 Mar 19;387(10024):1162. Boudoulas, Dean [corrected to Boudoulas, Konstantinos D.]]. Lancet. 2016;387(10016):349-356. doi:10.1016/S0140-6736(15)00515-2
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153836A/Anivamersen-sodium-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153836A/
Clinical Information
No Development Reported
CAS Number
959716-31-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
